2013 American Transplant Congress
Everolimus-Facilitated Reduction of Tacrolimus in De Novo Liver Transplant Recipients Achieves Comparable Overall Efficacy with Fewer Biopsy-Proven Acute Rejections Versus Standard Tacrolimus: 24-Month Results of a Randomized Trial
Purpose: The H2304 (NCT00622869) study compared the efficacy and safety of concentration-controlled everolimus (EVR) to eliminate or to reduce tacrolimus (TAC) vs standard TAC (TAC-C)…2013 American Transplant Congress
Lack of Clinical Factors Increasing Quantitative Interstitial Fibrosis after Renal Transplantation under a Lower Target Trough Strategy of Tacrolimus
INTRODUCTION AND OBJECTIVES: Chronic allograft injury is a multi-factorial process based on immunologic and non-immunologic factors. Patients with the CYP3A5*3/*3 genotype (non-expressers) require a lower…2013 American Transplant Congress
Suppression of Acute Rejection by Administration of Prostaglandin E2 Receptor Subtype 4 (EP4) Agonist in a Rat Heterotopic Small Bowel Transplantation Model
Background: Prostaglandin E2 (PGE2)–PGE2 receptor subtype 4 (EP4) signaling is known to modulate the inflammation process. Several studies have demonstrated the potential utility of EP4-selective…2013 American Transplant Congress
Kidney Injury Molecule-1 and Osteopontin: New Markers for Prediction of Early Kidney Transplant Rejection
Background. Kidney injury molecule-1 (KIM-1) and osteopontin (OPN) play important roles in immune regulation. We hypothesized that serum KIM-1 and OPN might serve as biomarkers…2013 American Transplant Congress
Health-Related Quality of Life and Adherence to Medication in Kidney Transplantation: A Longitudinal Analysis
AimTo analyse the influence of dialysis type on adherence to immunosupressive medications (IS) and HRQoL before and after KT.Material and Methods. Between years 2004-2008 156…2013 American Transplant Congress
Impact of Vitamin D, Bisphosphonate, and Combination Therapy on Bone Mineral Density in Kidney Transplant Patients
Background: Osteoporosis can develop and become aggravated in a large number of kidney transplant patients; however, the best preventive options for post-transplant osteoporosis remain controversial.Methods:…2013 American Transplant Congress
Influenza Vaccination and Humoral Alloimmunity in Solid Organ Transplant Recipients
Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland
Background: Annual influenza vaccination is usually recommended in solid-organ transplant (SOT) recipients. However, concerns have been raised about the impact of vaccination on alloimmunity. We…2013 American Transplant Congress
Prolonged Delayed Graft Function Is Associated with Inferior Patient and Kidney Allograft Survivals
Nephrology Division, Hospital do Rim e Hipertensão, São Paulo, Brazil
Introduction: The incidence of delayed graft function (DGF) is variable according to donor/recipients demographics. It is still unclear the influence of DGF on clinical outcomes…2013 American Transplant Congress
Successful Reduction and Cessation of Immunosuppressants by a Regulatory T Cell-Based Cell Therapy in Living Donor Liver Transplantation: A Pilot Study for Tolerance Induction
Purpose: Life-long use of immunosuppressants (IS) is associated with significant immunological and non-immunological adverse effects. Thus, minization, followed by complete cessation of IS has been…2013 American Transplant Congress
Carbapenem Resistant Klebsiella Pneumoniae (CRKP) Infection in Solid Organ Transplant Recipients (SOT): A Single Center Analysis
BACKGROUND: The incidence of Multi-drug-resistant bacterial infections among SOT recipients is steadily increasing. Aim of the present is to describe the epidemiology and outcome of…
- « Previous Page
- 1
- …
- 139
- 140
- 141
- 142
- 143
- …
- 178
- Next Page »